Ulcer Drug Recalled from Kenyan Market over cancer risk

0
602
Zantac

The Pharmacy and Poisons Board has issued a directive to recall all Ranitidine products from the Kenyan market.

Ranitidine is a drug used in management of ulcers. Recently, concerns were raised about the drug which was said to be contaminated with the chemical N-nitrosodimethylamine (NDMA), a potential cancer causing agent in humans.

In a letter by the board’s CEO Dr Siyoi addressed to company pharmacists, the board instructed the importers to carry out a level 2 recall as well as furnish the board with details of all Ranitidine products they had imported into the country.

Here is the statement;

Facebook Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here